Turn Therapeutics ($TTRX) to Ring the Closing Bell at Nasdaq

Home

A Revolutionary
Drug Delivery Engine

Targeting the limits of healing, our patented drug delivery platform, PermaFusion®, is breaking human barriers – quite literally.

See How Our Platform Works

The Origin of Our
Delivery Platform

Invented by our founder in search of a cure, PermaFusion® safely allows active pharmaceutical ingredients to penetrate skin, nails, and mucous membranes.

And it does so with maximum bioavailability and minimal concentration.

The Result

Minimizing

Toxicity

Minimizing

Irritation

Minimizing

Sensitization

How Permafusion Works

Play Video

The PermaFusion Advantage

Explore PermaFusion’s Potential

In a desperate bid to stop a life-threatening infection after conventional treatments failed, Founder & CEO Bradley Burnam developed a proprietary mixing technology that fuses liquid and oil, enabling active ingredients in liquid form to be delivered via an oil carrier.

This breakthrough allows our formulas to penetrate skin, nails, and mucous membranes, driving their effectiveness across a range of applications.

Pioneering Pharma

With Bradley’s relentless pursuit and mission to heal, our versatile delivery platform has driven three FDA cleared medical devices and is now powering our drug candidates for eczema and toenail fungus. The possibilities are limitless for PermaFusion® to be leveraged.

Explore
Our Portfolio

Explore
Our Pipeline

From Survivor to Founder

What started as a desperate attempt at survival, Founder and CEO Bradley Burnam laid the groundwork with PermaFusion to build a unique organization combining FDA cleared medical devices and a pipeline of drug candidates.

Moving ahead, Turn Therapeutics looks to rewrite the limits of healing.

The Story Behind Turn Therapeutics
  • Westlake Village, CA
  • 1-818-564-4011

Sign Up for Updates

Enter your information to receive the latest product updates and news from Turn Therapeutics.

Muhammad Zubair

Controller

Zubair, Controller, has 5+ years of accounting and finance management experience in companies ranging from medium-sized companies to pulicly traded multinationals. Zubair is a member of the Institute of Chartered Accountants of Pakistan and holds a Master’s degree in accounting & finance (Equivalent). 

Linkedin

Zuraiz Chaudhary, CPA

Chief Accounting Officer, VP Finance

Zuraiz, VP of Finance and Chief Accounting Officer, is a seasoned finance & accounting executive with more than a decade experience in working with PwC, EY and KPMG.  Zuraiz is a licensed CPA in California and Texas, has a bachelor’s in business administration from Asia-e University (Malaysia), is a member of the Institute of Chartered Accountants of Pakistan. Zuraiz specializes in financial reporting, SOX compliance and internal controls.

Linkedin

Dr. Neil Ghodadra, MD

Chief Medical Officer, Board Director

Dr. Neil Ghodadra, Board Certified Orthopedic Surgeon, joined Turn in Q3 2017. Renowned for surgical skill and orthopedic research, he graduated Magna Cum Laude from Duke University with a BS in Biology, and with Honors from Duke Medical School. His residency at Rush Medical Center focused on sports medicine, specializing in knee & shoulder surgery.

Linkedin

Bradley Burnam

Chief Executive Officer & Founder

Bradley Burnam, Founder & CEO, developed PermaFusion®, a patented drug delivery system, to combat his hospital-acquired skin infection. This innovation led to Hexagen™ Wound Dressing, Turn’s flagship product. Burnam, a self-taught regulatory and formulation expert, secured Turn’s first three FDA clearances solo before assembling a skilled team.

Linkedin

Subscribe to the Founder's Blog

Enter your information to subscribe for the latest updates from our Founder’s Blog.